Drug Manufacturers - Specialty & Generic
TXMD
1.29
price down icon7.86%   -0.11
after-market 시간 외 거래: 1.28 -0.01 -0.78%

Therapeuticsmd Inc (TXMD)
full-star
loading
개요 뉴스 가격 이력 옵션 체인 Financials 토론 예측 주식 분할
전일 마감가:
$1.40
열려 있는:
$1.4
하루 거래량:
84,810
Relative Volume:
5.40
시가총액:
$16.01M
수익:
$996.00K
순이익/손실:
$-6.09M
주가수익비율:
0.2873
EPS:
4.49
순현금흐름:
$-9.76M
1주 성능:
-15.13%
1개월 성능:
-19.38%
6개월 성능:
-41.89%
1년 성능:
-43.17%
1일 변동 폭
Value
$1.15
$1.45
1주일 범위
Value
$1.15
$1.55
52주 변동 폭
Value
$1.15
$3.07

Therapeuticsmd Inc Stock (TXMD) Company Profile

Name
명칭
Therapeuticsmd Inc
Name
부문
Healthcare (1196)
Name
산업
Drug Manufacturers - Specialty & Generic (87)
Name
전화
561-961-1900
Name
주소
951 YAMATO ROAD, SUITE 220, BOCA RATON, FL
Name
직원
1
Name
트위터
@TherapeuticsMD
Name
다음 수익 날짜
2024-11-12
Name
최신 SEC 제출 서류
Name
TXMD's Discussions on Twitter

TXMD을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
TXMD 1.29 16.01M 996.00K -6.09M -9.76M 4.49
ZTS 176.42 79.51B 9.15B 2.43B 2.31B 4.92
TAK 13.53 42.89B 30.27B 1.93B 3.45B 0.444
HLN 9.43 42.57B 14.26B 1.55B 0 0.3327
TEVA 16.49 18.51B 16.77B -959.00M 1.37B -2.00
VTRS 13.00 15.37B 15.24B -646.50M 1.88B 1.53

Therapeuticsmd Inc Stock (TXMD) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2020-08-07 다운그레이드 Jefferies Hold → Underperform
2020-05-19 다운그레이드 JP Morgan Overweight → Neutral
2019-12-02 개시 Guggenheim Buy
2019-10-17 개시 H.C. Wainwright Buy
2019-04-30 재개 Noble Capital Markets Outperform
2018-06-15 개시 JP Morgan Overweight
2017-09-08 개시 Morgan Stanley Equal-Weight
2017-07-11 업그레이드 Oppenheimer Perform → Outperform
2017-05-09 다운그레이드 Oppenheimer Outperform → Perform
2016-11-22 재개 Jefferies Buy
2016-11-22 개시 Oppenheimer Outperform
2016-11-07 재개 Guggenheim Buy
2016-04-04 개시 Goldman Buy
2015-12-08 재확인 Jefferies Buy
2015-12-08 재확인 Stifel Buy
2015-09-21 재확인 Jefferies Buy
2015-06-09 개시 Guggenheim Buy
2014-07-08 개시 FBR Capital Outperform
2014-04-17 재확인 Noble Financial Buy
2014-01-28 재확인 Noble Financial Buy
모두보기

Therapeuticsmd Inc 주식(TXMD)의 최신 뉴스

pulisher
Nov 15, 2024

TherapeuticsMD Inc. stock underperforms Friday when compared to competitors - MarketWatch

Nov 15, 2024
pulisher
Nov 15, 2024

TXMD stock touches 52-week low at $1.43 amid market challenges - Investing.com

Nov 15, 2024
pulisher
Nov 15, 2024

TherapeuticsMD Third Quarter 2024 Earnings: US$0.049 loss per share (vs US$0.13 loss in 3Q 2023) - Yahoo Finance

Nov 15, 2024
pulisher
Nov 15, 2024

TherapeuticsMD, Inc. (NASDAQ:TXMD) Sees Large Increase in Short Interest - Defense World

Nov 15, 2024
pulisher
Nov 14, 2024

TherapeuticsMD Inc. stock underperforms Thursday when compared to competitors - MarketWatch

Nov 14, 2024
pulisher
Nov 13, 2024

TherapeuticsMD Inc. stock outperforms competitors despite losses on the day - MarketWatch

Nov 13, 2024
pulisher
Nov 12, 2024

TherapeuticsMD Reports Reduced Losses Amid Strategic Shift - TipRanks

Nov 12, 2024
pulisher
Nov 12, 2024

TherapeuticsMD: Q3 Earnings Snapshot - Houston Chronicle

Nov 12, 2024
pulisher
Nov 12, 2024

TherapeuticsMD Inc (TXMD) Reports Third Quarter 2024 Earnings: S - GuruFocus.com

Nov 12, 2024
pulisher
Nov 12, 2024

TherapeuticsMD Shifts Focus with Lower Q3 Losses - TipRanks

Nov 12, 2024
pulisher
Nov 12, 2024

TherapeuticsMD Narrows Q3 Loss by 60%, Weighs Strategic Options Amid Revenue Growth | TXMD Stock News - StockTitan

Nov 12, 2024
pulisher
Nov 11, 2024

TherapeuticsMD Inc. stock remains steady Monday, underperforms market - MarketWatch

Nov 11, 2024
pulisher
Nov 08, 2024

TherapeuticsMD Inc. stock remains steady Friday, underperforms market - MarketWatch

Nov 08, 2024
pulisher
Nov 06, 2024

TherapeuticsMD Inc. stock remains steady Wednesday, underperforms market - MarketWatch

Nov 06, 2024
pulisher
Nov 05, 2024

TherapeuticsMD Inc. stock underperforms Tuesday when compared to competitors - MarketWatch

Nov 05, 2024
pulisher
Nov 04, 2024

TherapeuticsMD Inc. stock outperforms competitors on strong trading day - MarketWatch

Nov 04, 2024
pulisher
Oct 31, 2024

TherapeuticsMD Inc. stock remains steady Thursday, still outperforms market - MarketWatch

Oct 31, 2024
pulisher
Oct 30, 2024

TherapeuticsMD Inc. stock underperforms Wednesday when compared to competitors - MarketWatch

Oct 30, 2024
pulisher
Oct 29, 2024

TherapeuticsMD Inc. stock rises Tuesday, still underperforms market - MarketWatch

Oct 29, 2024
pulisher
Oct 28, 2024

TherapeuticsMD Inc. stock underperforms Monday when compared to competitors - MarketWatch

Oct 28, 2024
pulisher
Oct 24, 2024

TherapeuticsMD Inc. stock rises Thursday, still underperforms market - MarketWatch

Oct 24, 2024
pulisher
Oct 22, 2024

TherapeuticsMD Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch

Oct 22, 2024
pulisher
Oct 17, 2024

TherapeuticsMD Inc. stock remains steady Thursday, underperforms market - MarketWatch

Oct 17, 2024
pulisher
Oct 03, 2024

Sexual Wellness Market to Witness 4.7% CAGR by 2031 | SkyQuest Technology - Benzinga

Oct 03, 2024
pulisher
Sep 30, 2024

TherapeuticsMD Inc. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch

Sep 30, 2024

Therapeuticsmd Inc (TXMD) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

TXMD과 유사한 종목

drug_manufacturers_specialty_generic LNTH
$76.22
price down icon 0.79%
drug_manufacturers_specialty_generic ELAN
$13.45
price down icon 3.79%
drug_manufacturers_specialty_generic ITCI
$82.47
price down icon 1.14%
drug_manufacturers_specialty_generic CTLT
$58.78
price down icon 0.54%
drug_manufacturers_specialty_generic NBIX
$117.62
price up icon 0.15%
drug_manufacturers_specialty_generic VTRS
$13.00
price up icon 1.33%
야후에서 열기 | 구글에서 열기 | 핀비즈에서 열기 | MarketWatch에서 열기 | EDGAR에서 열기 | 로이터에서 공개
자본화:     |  볼륨(24시간):